Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with community-acquired pneumonia

M.F. Engel, D.F. Postma, M.E.J.L. Hulscher, F. Teding van Berkhout, M.H. Emmelot-Vonk, S. Sankatsing, C.A.J.M. Gaillard, A.H.W. Bruns, A.I.M. Hoepelman, J.J. Oosterheert
European Respiratory Journal 2012; DOI: 10.1183/09031936.00029412
M.F. Engel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.f.engel-2@umcutrecht.nl
D.F. Postma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.E.J.L. Hulscher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Teding van Berkhout
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.H. Emmelot-Vonk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Sankatsing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.A.J.M. Gaillard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.H.W. Bruns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.I.M. Hoepelman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.J. Oosterheert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.j.oosterheert@umcutrecht.nl
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Do physicians apply an early switch strategy (from intravenous (IV) to oral antibiotics) in clinically stable patients hospitalised with community-acquired pneumonia (CAP)? If not, why not?

In a multicenter prospective cohort study, adult patients admitted for IV CAP treatment were included. On day 3 of antibiotic treatment, clinical stability was assessed and treating residents were interviewed on their switch strategies. Additionally, treating physicians were interviewed to evaluate their knowledge of and adherence to guideline advice.

149/162 (92%) Patients were included and 97/107 (91%) physicians were interviewed. A switch to oral antibiotics was possible in 68/149 (46%) patients on day 3 of treatment, but not performed in 27/68 (40%). Patient factors delaying the switch were high CURB-score (admission) (p 0.04) and oxygen treatment (p 0.04), high temperature (p 0.00) and high respiration rate (p 0.04) (day 3). Physicians' barriers to an early switch in clinically stable patients included misconceptions (26/47, 55%), practical considerations (13/47, 28%) and organisational factors (8/47, 17%). Strikingly, 91/97 (94%) physicians were not aware of guideline advice.

The switch from IV to oral antibiotics is often unnecessary delayed in patients hospitalised with CAP due to different types of barriers.

  • Antibiotic treatment
  • community acquired pneumonia
  • ERS
Next
Back to top
Vol 62 Issue 3 Table of Contents
European Respiratory Journal: 62 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with community-acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with community-acquired pneumonia
M.F. Engel, D.F. Postma, M.E.J.L. Hulscher, F. Teding van Berkhout, M.H. Emmelot-Vonk, S. Sankatsing, C.A.J.M. Gaillard, A.H.W. Bruns, A.I.M. Hoepelman, J.J. Oosterheert
European Respiratory Journal Jan 2012, erj00294-2012; DOI: 10.1183/09031936.00029412

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with community-acquired pneumonia
M.F. Engel, D.F. Postma, M.E.J.L. Hulscher, F. Teding van Berkhout, M.H. Emmelot-Vonk, S. Sankatsing, C.A.J.M. Gaillard, A.H.W. Bruns, A.I.M. Hoepelman, J.J. Oosterheert
European Respiratory Journal Jan 2012, erj00294-2012; DOI: 10.1183/09031936.00029412
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Sputum induction to aid diagnosis of tuberculosis in HIV
  • Predicting Mycobacterium tuberculosis in CAP patients
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society